Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 1.85T | 1.81T | 1.67T | 1.57T | 1.21T | 1.05T |
Gross Profit | 1.32T | 1.29T | 1.16T | 1.07T | 773.40B | 628.48B |
EBITDA | 388.62B | 361.30B | 306.81B | 325.25B | 283.52B | 235.69B |
Net Income | 127.41B | 113.20B | 178.87B | 77.32B | 70.14B | 81.67B |
Balance Sheet | ||||||
Total Assets | 8.97T | 9.04T | 8.59T | 7.11T | 6.70T | 3.93T |
Cash, Cash Equivalents and Short-Term Investments | 1.26T | 1.42T | 1.65T | 1.13T | 1.07T | 880.10B |
Total Debt | 1.83T | 1.88T | 1.91T | 1.67T | 1.39T | 1.09T |
Total Liabilities | 5.50T | 5.60T | 5.27T | 4.13T | 3.71T | 2.89T |
Stockholders Equity | 3.08T | 3.04T | 2.92T | 2.68T | 2.68T | 771.55B |
Cash Flow | ||||||
Free Cash Flow | 367.12B | 245.47B | -55.94B | -6.32B | 137.18B | 158.15B |
Operating Cash Flow | 389.66B | 316.48B | 93.05B | 266.31B | 207.92B | 243.28B |
Investing Cash Flow | -484.95B | -444.06B | 319.79B | -303.90B | -12.35B | -503.03B |
Financing Cash Flow | -48.85B | -81.49B | 105.79B | 91.63B | -12.07B | 593.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $21.30B | 19.60 | 51.10% | 1.52% | 1.64% | 8.57% | |
77 Outperform | $35.20B | 18.25 | 36.48% | 1.52% | 2.04% | -15.61% | |
74 Outperform | $54.99B | 219.02 | 6.06% | ― | 20.88% | -80.08% | |
72 Outperform | $24.73B | 26.15 | 5.01% | 0.65% | -1.16% | -6.96% | |
64 Neutral | $7.01B | 8.86 | -52.83% | 2.41% | -0.93% | -4.07% | |
64 Neutral | $5.67B | 38.62 | -39.97% | ― | 2.18% | -32.87% | |
62 Neutral | $16.85B | 11.50 | -7.38% | 2.96% | 1.59% | -23.36% |